Table 3.
Isolate no. | Cip | T | C | K | NA |
---|---|---|---|---|---|
1-E | 0.009 | 0.029 | 0.234 | 0.029 | 0.234 |
2-E | 0.019 | 0.468 | 0.468 | 0.058 | 0.234 |
4-E | 0.009 | 0.117 | 0.468 | 0.117 | 0.058 |
5-E | 0.625 | 3.75 | 0.937 | ND | 0.234 |
7-E | 0.004 | 0.117 | 0.234 | 0.117 | 0.117 |
09-2 | 0.004 | 0.117 | 0.468 | 0.058 | 0.029 |
012-2 | 0.156 | 0.468 | 0.468 | 0.029 | 0.234 |
052-2 | 0.009 | 0.234 | 0.937 | 0.117 | 0.234 |
057-2 | 0.009 | 0.117 | 0.468 | 0.117 | 0.058 |
067-2 | 0.019 | 0.468 | 0.468 | 0.058 | 0.117 |
070-2 | 0.004 | 0.117 | 0.937 | 0.058 | 0.234 |
073-2 | 0.009 | 0.234 | 0.468 | 0.014 | 0.058 |
089-2 | 0.009 | 0.117 | 0.058 | 0.029 | 0.468 |
103-1 | 0.019 | 0.234 | 0.468 | 0.058 | 0.117 |
112-3 | 0.004 | 0.058 | 0.937 | 0.117 | 0.117 |
224-3 | 0.009 | 0.117 | 0.468 | 0.234 | 0.117 |
247-2 | 0.019 | 0.117 | 0.637 | 0.234 | 0.468 |
114-2 | 0.009 | 0.117 | 0.058 | 0.117 | 0.468 |
119-2 | 0.019 | 0.117 | 0.468 | 0.058 | 0.029 |
164-1 | 0.004 | 0.029 | 0.468 | 0.058 | 0.468 |
171-1 | 0.625 | ND | 0.468 | ND | 0.937 |
172-1 | 0.625 | ND | 0.937 | ND | 0.234 |
177-1 | 0.019 | 0.937 | 0.468 | 0.058 | 0.117 |
194-3 | 0.009 | 0.117 | 0.234 | 0.029 | 0.234 |
198-2 | 0.004 | 0.468 | 0.468 | 0.058 | 0.234 |
205-3 | 0.004 | 0.117 | 0.937 | 0.117 | 0.029 |
208-2 | 0.156 | 0.468 | 0.468 | 0.117 | 0.234 |
217-3 | 0.312 | ND | 0.234 | 0.029 | 0.468 |
220-2 | 0.009 | 0.468 | 0.234 | 0.029 | 0.234 |
221-2 | 0.004 | 0.234 | 0.468 | 0.117 | 0.029 |
225-3 | 0.009 | 0.234 | 0.937 | 0.117 | 0.117 |
235-2 | 0.312 | ND | 0.468 | ND | 0.937 |
251-3 | 0.156 | ND | 0.234 | 0.117 | 0.029 |
Cip, ciprofloxacin; T, tetracycline; K, kanamycin; NA, nalidixic acid; C, chloramphenicol; ND, not determined.